ADHD - Attention Deficit Disorder With Hyperactivity

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Plus Therapeutics
1 program
Intermittent Theta Burst Stimulation to Right DLPFCN/A1 trial
Active Trials
NCT07182344Enrolling By InvitationEst. Jun 2026

Trial Timeline

Clinical trial activity over time

2025
2026
Plus TherapeuticsIntermittent Theta Burst Stimulation to Right DLPFC

Clinical Trials (1)

NCT07182344Plus TherapeuticsIntermittent Theta Burst Stimulation to Right DLPFC

Brain Stimulation and Attention Control in Children With ADHD

Start: Sep 2025Est. completion: Jun 2026
N/AEnrolling By Invitation

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space